Distribution of Brevetoxin to Lipoproteins in human plasma

Toxicon

Volumn 49, Issue 7, 2007, Pages 1010-1018

  Woofter, Ricky T ^a   Ramsdell, John S ^a  

^a CENTER FOR COASTAL ENVIRONMENTAL HEALTH AND BIOMOLECULAR RESEARCH   (United States)

Author keywords

Brevetoxin; Lipoprotein; Plasma

Indexed keywords

BREVETOXIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLASMA PROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EQUILIBRIUM DIALYSIS; HUMAN; LIPID MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN INTERACTION; SCINTILLATION;

ANIMALS; CHEMICAL FRACTIONATION; DINOFLAGELLIDA; HUMANS; LIPOPROTEINS; MARINE TOXINS; OXOCINS; SERUM ALBUMIN;

EID: 34247627860     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2007.01.011     Document Type: Article

References (32)

1. Baker M.E. Beyond carrier proteins: albumin, steroid hormones and the origin of vertebrates. J. Endocrinol. 175 (2002) 121-127
2. Cassidy S.M., Strobel F.W., and Wasan K.M. Plasma lipoprotein distribution of liposomal nystatin is influenced by protein content of high-density lipoproteins. Antimicrob. Agents Chemother. 42 (1998) 1878-1888
3. Cattet M., and Geraci J.R. Distribution and elimination of ingested brevetoxin (PbTx-3) in rats. Toxicon 31 11 (1993) 1483-1486
4. Chou H.-N., and Shimizu Y. A new polyether toxin from Gymnodinium breve Davis. Tetrahedron Letters 23 52 (1982) 5521
5. Chung N.S., and Wasan K.M. Potential role of the low-density lipoprotein family as mediators of cellular drug uptake. Advanced Drug Delivery Rev. 56 (2004) 1315-1334
6. Davis C.C. Gymnodinium breve: a cause of discolored water and animal mortality in the Gulf of Mexico. Bot. Gaz. 109 (1948) 358-360
7. Davis R.A., and Vance J.E. Structure, assembly and Secretion of lipoproteins. In: Vance D.E., and Vance J.E. (Eds). Biochemistry of Lipids, Lipoproteins and membranes (1996), Elsevier, New York 473-493
8. De Silva P.P., Agarwal-Mawal A., Davis P.J., and Cheema S.K. The levels of plasma low density lipoprotein are independent of cholesterol ester transfer protein in fish-oil fed F1B hamsters. Nutrition and Metabolism 2 1 (2005) 8
9. De Smidt P.C., and van Berkel T.J.C. Prolonged serum half-life of antineoplastic drugs by incorporation into the low density lipoproteins. Cancer Res. 50 (1990) 7476-7482
10. Fairey E.R., Shuart N.G., Busman M., Moeller P.D., and Ramsdell J.S. Biomonitoring brevetoxin exposure in mammals using blood collection cards. Environ. Health Perspect. 109 7 (2001) 717-720
11. Gawley R.E., Rein K.S., Jeglitsch G., Adams D.J., Theodorakis E.A., Tiebes J., et al. The relationship of brevetoxin 'length' and A-ring functionality to binding and activity in neuronal sodium channels. Chem. Biol. 2 8 (1995) 533-541
12. Harmony J.A.K., Aleson A.L., and McCarthy B.M. Lipoprotein structure. In: Scanu A.M., and Spector A.A. (Eds). Biochemistry and Biology of Plasma Lipoproteins (1986), Marcel Dekker Inc., New York 403-430
13. Kennedy A.L., and Wasan K.M. Preferential distribution of amphotericin B lipid complex into human HDL3 is a consequence of high density lipoprotein coat lipid content. J. Pharm. Sci. 8 (1999) 1149-1155
14. Kragh-Hansen U. Molecular aspects of the ligand binding to serum albumin. Pharmacol. Rev. 33 (1981) 17-53
15. Lemaire M., and Tillement J.P. Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporine A in the blood. J. Pharm. Pharmacol. 34 (1982) 715-718
16. Landsberg J.H. The effects of harmful algal blooms on aquatic organisms. Rev. Fish. Sci. 10 (2002) 113-390
17. Lin Y., Risk M., Ray S.M., Van Engen D., Clardy J., Golik J., et al. Isolation and structure of brevetoxin B from the "red tide" dinoflagellate Ptychodiscus brevis (Gymnodinium breve). J. Am. Chem. Soc. 103 (1981) 6773-6775
18. McFarren E.F., Silva F.J., Tanabe H., Wilson W.B., Campbell J.E., and Lewis K.H. The occurrence of a ciguatera-like poison in oysters, clams, and Gymnodinium breve cultures. Toxicon 3 2 (1965) 111-123
19. Mills G.L., and Taylaur C.E. The distribution and composition of serum lipoproteins in eighteen animals. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 40 (1971) 489-498
20. Niederberger W., Lemaire M., Maurer G., Nussbaumer K., and Wagner O. Distribution and binding of cyclosporine in blood and tissue. Transplant. Proc. 15 (1983) 2412-2419
21. Poli M.A., Templeton C.B., Thompson W.L., and Hewetson J.F. Distribution and elimination of brevetoxin PbTx-3 in rats. Toxicon 28 8 (1990) 903-910
22. Radwan F.F., and Ramsdell J.S. Characterization of in vitro oxidative and conjugative metabolic pathways for brevetoxin (PbTx-2). Toxicol. Sci. 89 (2006) 57-65
23. Radwan F.F., Wang Z., and Ramsdell J.S. Identification of a rapid detoxification mechanism for brevetoxin in rats. Toxicol. Sci. 85 2 (2005) 839-846
24. Rein K.S., Baden D.G., and Gawley R.E. Conformational analysis of the sodium channel modulator, brevetoxin A, comparison with brevetoxin B conformations, and a hypothesis about the common pharmacophore of the "site 5" toxins. J. Organic Chem. 59 8 (1994) 2101-2106
25. Shimizu Y., Chou H.N., and Bando H. Structure of brevetoxin A (GB-1 Toxin), the most potent toxin in the Florida red tide organism Gymnodinium breve (Ptychodiscus brevis). J. Am. Chem. Soc. 108 (1986) 514-515
26. Taylor, H.F., 1917. Mortality of fishes on the west coast of Florida. Report of the US Commissioner of Fisheries. Beureau of Fisheries Document 848. Washington, DC: Government Printing Office, 1917 Rep US Comm Fish Doc No. 848. App III. p. 24.
27. Wasan K.M., Pritchard P.H., Ramaswamy M., Wong W., Donnachie E.M., and Brunner L.J. Differences in lipoprotein lipid concentration and composition modify the plasma distribution of cyclosporine. Pharm. Res. 14 (1997) 1614-1621
28. Wasan K.M. Modifications in plasma lipoprotein concentration and lipid composition regulate the biological activity of hydrophobic drugs. J. Pharmacol. Toxicol. Methods 36 1 (1996) 1-11
29. Woodcock A.H. Note concerning human respiratory irritation associated with high concentrations of plankton and mass mortality of marine organisms. J. Mar. Res. 7 1 (1948) 56-62
30. Woofter R., Dechraoui M.Y., Garthwaite I., Towers N.R., Gordon C.J., Cordova J., et al. Measurement of brevetoxin levels by radioimmunoassay of blood collection cards after acute, long-term, and low-dose exposure in mice. Environ. Health Perspect. 111 13 (2003) 1595-1600
31. Woofter R.T., Brendtro K., and Ramsdell J.S. Uptake and elimination of brevetoxin in blood of striped mullet (Mugil cephalus) after aqueous exposure to Karenia brevis. Environ. Health Perspect. 113 1 (2005) 11-16
32. Woofter R.T., Spiess P.C., and Ramsdell J.S. Distribution of brevetoxin (PbTx-3) in mouse plasma: association with high-density lipoproteins. Environ. Health Perspect. 113 11 (2005) 1491-1496